(S (NP (NNP COVID-19)) (VP (VBZ has) (VP (VBN shown) (NP (DT a) (ADJP (RB relatively) (JJ low)) (NN mortality) (NN rate)) (PP (IN in) (NP (JJ young) (JJ healthy) (NNS individuals))) (, ,) (PP (IN with) (S (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (DT this) (NN group)))) (VP (VP (VBG being) (ADJP (JJ asymptomatic))) (CC or) (VP (VBG having) (NP (JJ mild) (NNS symptoms)))))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (DT the) (NN disease))) (PP (IN among) (NP (NP (NNS individuals)) (PP (IN with) (NP (JJ underlying) (NN health) (NNS conditions)))))) (VP (VBZ has) (VP (VBN caused) (NP (JJ signiffcant) (NN mortality) (NNS rates)) (ADVP (VBP worldwide)))))))) (. .))
(S (S (VP (VP (VBG Understanding) (NP (NP (DT these) (NNS differences)) (PP (IN in) (NP (NN mortality))) (PP (VBP amongst) (NP (NP (JJ different) (NNS sectors)) (PP (IN of) (NP (NN society))))))) (CC and) (VP (VBG modelling) (NP (DT this))))) (VP (MD will) (VP (VB enable) (S (NP (NP (DT the) (JJ different) (NNS levels)) (PP (IN of) (NP (NN risk) (CC and) (NNS vulnerabilities)))) (VP (TO to) (VP (VB be) (VP (VBN determined) (S (VP (TO to) (VP (VB enable) (S (NP (NNS strategies)) (VP (VBP exit) (NP (DT the) (NN lockdown))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (JJ epidemiological) (NNS models)) (VP (VBP do) (RB not) (VP (VB account) (PP (IN for) (NP (NP (DT the) (NN variability)) (VP (VBN encountered) (PP (IN in) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (DT the) (NNP SARS-CoV-2) (NN disease))))) (PP (IN across) (NP (JJ different) (NN population) (NNS groups)))))))) (. .))
(S (S (VP (TO To) (VP (VB overcome) (NP (DT this) (NN limitation))))) (, ,) (NP (NP (PRP it))) (VP (VBZ is) (VP (VBN proposed) (SBAR (IN that) (S (NP (NP (DT a) (FW modiffed) (NNP SEIR) (NN model)) (, ,) (ADVP (RB namely)) (NP (NNP SEIR-v)) (, ,) (SBAR (WHPP (IN through) (WHNP (WDT which))) (S (NP (DT the) (NN population)) (VP (VBZ is) (VP (VBN separated) (PP (IN into) (NP (CD two) (NNS groups))) (PP (VBG regarding) (NP (NP (PRP$ their) (NN vulnerability)) (PP (TO to) (NP (NNP SARS-CoV-2)))))))))) (VP (VBZ is) (VP (VBN applied))))))) (. .))
(S (NP (DT This)) (VP (VBZ enables) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN spread)) (PP (IN of) (NP (DT the) (JJ epidemic)))))) (SBAR (WHADVP (WRB when)) (S (NP (JJ different) (NN contention) (NNS measures)) (VP (VBP are) (VP (VBN applied) (PP (TO to) (NP (NP (JJ different) (NNS groups)) (PP (IN in) (NP (NN society))))) (PP (VBG regarding) (NP (NP (PRP$ their) (NN vulnerability)) (PP (TO to) (NP (DT the) (NN disease)))))))))) (. .))
(S (NP (DT A) (NNP Monte) (NNP Carlo) (NN simulation)) (VP (VBZ indicates) (SBAR (S (NP (NP (DT a) (JJ large) (NN number)) (PP (IN of) (NP (NNS deaths)))) (VP (MD could) (VP (VB be) (VP (VBN avoided) (PP (IN by) (S (VP (ADVP (RB slightly)) (VBG decreasing) (NP (NP (DT the) (NN exposure)) (PP (IN of) (NP (JJ vulnerable) (NNS groups))) (PP (TO to) (NP (DT the) (NN disease))))))))))))) (. .))
(S (PP (IN From) (NP (DT this) (VBG modelling))) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNS mechanisms)))) (VP (MD can) (VP (VB be) (VP (VBN proposed) (S (VP (TO to) (VP (VB limit) (NP (NP (DT the) (NN exposure)) (PP (IN of) (NP (JJ vulnerable) (NNS individuals))) (PP (TO to) (NP (DT the) (NN disease)))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (NN mortality) (NN rate)) (PP (IN among) (NP (DT this) (NN group)))))))))))))) (. .))
(S (NP (CD One) (NN option)) (VP (MD could) (VP (VB be) (NP (NP (DT the) (NN provision)) (PP (IN of) (NP (DT a) (NN wristband))) (PP (TO to) (NP (NP (JJ vulnerable) (NNS people)) (CC and) (NP (NP (DT those)) (PP (IN without) (NP (DT a) (JJ contact-tracing) (NN app))))))))) (. .))
(S (PP (IN By) (S (VP (VBG combining) (NP (NP (ADJP (RB very) (JJ dense)) (NN contact) (VBG tracing) (NNS data)) (PP (IN from) (NP (NP (NN smartphone) (NN apps)) (CC and) (NP (NN wristband) (NNS signals))))) (PP (IN with) (NP (NP (NN information)) (PP (IN about) (NP (NP (NN infection) (NN status)) (CC and) (NP (NNS symptoms))))))))) (, ,) (NP (JJ vulnerable) (NNS people)) (VP (MD can) (VP (VB be) (VP (VP (VBN protected)) (CC and) (VP (VBN kept) (S (ADJP (NN safer))))))) (. .))
(S (NP (JJ Widespread) (NN utilisation)) (VP (MD would) (VP (VB extend) (NP (DT the) (NN protection)) (PP (ADVP (RB further)) (IN beyond) (NP (DT these) (JJ high) (NN risk) (NNS groups))))) (. .))
